Retroviral restriction by APOBEC proteins - PubMed (original) (raw)
Review
doi: 10.1038/nri1489.
Affiliations
- PMID: 15516966
- DOI: 10.1038/nri1489
Review
Retroviral restriction by APOBEC proteins
Reuben S Harris et al. Nat Rev Immunol. 2004 Nov.
Abstract
A powerful mechanism of vertebrate innate immunity has been discovered in the past year, in which APOBEC proteins inhibit retroviruses by deaminating cytosine residues in nascent retroviral cDNA. To thwart this cellular defence, HIV encodes Vif, a small protein that mediates APOBEC degradation. Therefore, the balance between APOBECs and Vif might be a crucial determinant of the outcome of retroviral infection. Vertebrates have up to 11 different APOBEC proteins, with primates having the most. APOBEC proteins include AID, a probable DNA mutator that is responsible for immunoglobulin-gene diversification, and APOBEC1, an RNA editor with antiretroviral activities. This APOBEC abundance might help to tip the balance in favour of cellular defences.
Similar articles
- APOBEC deaminases as cellular antiviral factors: a novel natural host defense mechanism.
Franca R, Spadari S, Maga G. Franca R, et al. Med Sci Monit. 2006 May;12(5):RA92-8. Med Sci Monit. 2006. PMID: 16641889 Review. - The Vif protein of HIV triggers degradation of the human antiretroviral DNA deaminase APOBEC3G.
Conticello SG, Harris RS, Neuberger MS. Conticello SG, et al. Curr Biol. 2003 Nov 11;13(22):2009-13. doi: 10.1016/j.cub.2003.10.034. Curr Biol. 2003. PMID: 14614829 - Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts.
Mangeat B, Turelli P, Caron G, Friedli M, Perrin L, Trono D. Mangeat B, et al. Nature. 2003 Jul 3;424(6944):99-103. doi: 10.1038/nature01709. Epub 2003 May 28. Nature. 2003. PMID: 12808466 - APOBEC-mediated editing of viral RNA.
Bishop KN, Holmes RK, Sheehy AM, Malim MH. Bishop KN, et al. Science. 2004 Jul 30;305(5684):645. doi: 10.1126/science.1100658. Science. 2004. PMID: 15286366 - APOBEC-mediated viral restriction: not simply editing?
Holmes RK, Malim MH, Bishop KN. Holmes RK, et al. Trends Biochem Sci. 2007 Mar;32(3):118-28. doi: 10.1016/j.tibs.2007.01.004. Epub 2007 Feb 15. Trends Biochem Sci. 2007. PMID: 17303427 Review.
Cited by
- APOBEC3B expression in 293T viral producer cells drives mutations in chimeric antigen receptors and reduces CAR T cell efficacy.
Swanson J, Tonne J, Sangsuwannukul T, Thompson J, Kendall B, Liseth O, Metko M, Vile R. Swanson J, et al. Mol Ther Oncol. 2024 Sep 10;32(4):200873. doi: 10.1016/j.omton.2024.200873. eCollection 2024 Dec 19. Mol Ther Oncol. 2024. PMID: 39403625 Free PMC article. - HIV-1 env gene mutations outside the targeting probe affects IPDA efficiency.
Zhou Z, Zhang X, Wang M, Jiang F, Tong J, Nie J, Zhao C, Zheng H, Zhang Z, Shi P, Fan W, Wang Y, Huang W. Zhou Z, et al. iScience. 2024 May 8;27(6):109941. doi: 10.1016/j.isci.2024.109941. eCollection 2024 Jun 21. iScience. 2024. PMID: 38812543 Free PMC article. - The Disassociation of A3G-Related HIV-1 cDNA G-to-A Hypermutation to Viral Infectivity.
Martin J, Chen X, Jia X, Shao Q, Liu B. Martin J, et al. Viruses. 2024 May 4;16(5):728. doi: 10.3390/v16050728. Viruses. 2024. PMID: 38793610 Free PMC article. - Synthesis of 1,4-azaphosphinine nucleosides and evaluation as inhibitors of human cytidine deaminase and APOBEC3A.
Kvach MV, Harjes S, Kurup HM, Jameson GB, Harjes E, Filichev VV. Kvach MV, et al. Beilstein J Org Chem. 2024 May 15;20:1088-1098. doi: 10.3762/bjoc.20.96. eCollection 2024. Beilstein J Org Chem. 2024. PMID: 38774272 Free PMC article. - Design of Vif-Derived Peptide Inhibitors with Anti-HIV-1 Activity by Interrupting Vif-CBFβ Interaction.
Gai Y, Duan S, Wang S, Liu K, Yu X, Yang C, Li G, Zhou Y, Yu B, Wu J, Wang C, Yu X. Gai Y, et al. Viruses. 2024 Mar 22;16(4):490. doi: 10.3390/v16040490. Viruses. 2024. PMID: 38675833 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous